ORIC Pharmaceuticals, Inc.
ORICNASDAQHealthcare● Active
$7.56
+$0.06(+0.73%)
Market Cap$782075181
P/E Ratio—
52W High$14.93
52W Low$7.23
ORIC Pharmaceuticals, Inc. (ORIC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORIC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.11B | $0.11B | $0.09B | $0.06B | $0.06B |
| G&A Expenses | $0.03B | $0.03B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.14B | $0.14B | $0.11B | $0.09B | $0.08B |
| Operating Income | ($0.14B) | ($0.14B) | ($0.11B) | ($0.09B) | ($0.08B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.13B) | ($0.13B) | ($0.10B) | ($0.09B) | ($0.08B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.13B) | ($0.13B) | ($0.10B) | ($0.09B) | ($0.08B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 |
| Wtd Avg Shares | 0.09B | 0.07B | 0.05B | 0.04B | 0.04B |
| EBITDA | ($0.13B) | ($0.13B) | ($0.11B) | ($0.09B) | ($0.08B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more ORIC Pharmaceuticals, Inc. data
About ORIC Pharmaceuticals, Inc. (ORIC) Income Statement
ORIC Pharmaceuticals, Inc. (ORIC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ORIC reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.13B) — a net profit margin of —.
Frequently asked questions
ORIC · 4 questionsORIC Pharmaceuticals, Inc. (ORIC) reported revenue of $0.00B for 2025, down —% year-over-year.
ORIC revenueORIC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08